Kimball Electronics, Inc.

Kimball Electronics, Inc. (KE) Market Cap

Kimball Electronics, Inc. has a market capitalization of $594.7M.

Price: $24.73

0.15 (0.61%)

Market Cap: 594.73M

NASDAQ · time unavailable

CEO: Richard D. Phillips

Sector: Industrials

Industry: Electrical Equipment & Parts

IPO Date: 2014-11-03

Website: https://www.kimballelectronics.com

Kimball Electronics, Inc. (KE) - Company Information

Market Cap: 594.73M|Sector: Industrials

Company Profile

Kimball Electronics, Inc. specializes in providing comprehensive contract electronics manufacturing (CEM) and an array of diversified production solutions, catering to clients across the automotive, medical, industrial, and public safety sectors. Their extensive service portfolio encompasses initial design and development support, robust supply chain management, and agile rapid prototyping alongside streamlined product introduction capabilities. Key competencies also include comprehensive product design, rigorous process validation and qualification, and the industrialization and automation of complex manufacturing workflows. The company excels in reliability testing, subjecting products to a range of environmental conditions, and is proficient in the production and testing of printed circuit board assemblies. They also handle the assembly, production, and packaging of medical devices, including disposables and other non-electronic items, as well as electronic and non-electronic drug delivery systems. Additionally, their expertise extends to the design engineering and manufacturing of automation equipment, test and inspection equipment, and precision molded plastics, complemented by software design services and holistic product life cycle management. With a significant global operational presence, Kimball Electronics conducts business in the United States, China, Mexico, Poland, Romania, Thailand, and Vietnam. Founded in 1961, the company maintains its headquarters in Jasper, Indiana.

Analyst Sentiment

75%
Strong Buy

From 4 Active Polls

1Y Forecast: $26.00

▲ +5.1% Potential Upside

Consensus Target Metrics

Low Bound

$20

Median

$26

High Bound

$32

Average

$26

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$26.00
▲ +5.14% Upside
Low Target
$20.00
-19% Risk
Median Target
$26.00
5% Mid
High Target
$32.00
29% Max
Consensus
Buy
3 / 5 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)595580685735472407466462540
Enterprise Value ($M)690675760796530534616632757
Price to Earnings Ratio (P/E)23.3325.7546.3718.2117.8127.4233.4535.6017.97
Price/Earnings-to-Growth Ratio (PEG)7.5511.375.6914.91
Price to Sales Ratio (P/S)0.411.642.012.011.241.091.301.241.26
Price to Book Ratio (P/B)1.051.001.181.270.830.740.870.841.00
Price to Free Cash Flow Ratio (P/FCF)7.101260.1539.23-293.246.9015.1020.2914.4013.71
Enterprise Value to Sales (EV/Sales)1.912.232.181.391.421.721.691.76
Enterprise Value to EBITDA (EV/EBITDA)7.8630.8041.3835.4721.1527.7436.7437.4426.71
Debt to Equity Ratio1.090.310.270.240.260.330.380.450.55

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

```html

📘 KIMBALL ELECTRONICS INC (KE) — Investment Overview

🧩 Business Model Overview

Kimball Electronics (KE) operates as an electronics manufacturing services (EMS) provider, offering end-to-end production support for complex electronic products. The value chain typically spans:

  • Program development support: engineering collaboration during design-for-manufacturing (DFM), prototyping, and new product introduction (NPI).
  • Manufacturing and assembly: building electronic components and systems through PCB-related processes, advanced assembly, integration, testing, and “box-build” level work where required by customer specifications.
  • Lifecycle support: sustaining production once programs ramp, plus ongoing quality, testing, and documentation requirements that customers depend on for regulatory and operational continuity.

Customer stickiness in EMS is driven less by “brand” and more by qualification processes, quality history, and the operational cost of switching suppliers once a product is in production.

💰 Revenue Streams & Monetisation Model

KE monetizes primarily through contract manufacturing arrangements that combine engineering and production services:

  • NPI / engineering-related revenue: typically tied to program launches and prototype-to-production transitions.
  • Production manufacturing revenue: ongoing unit-based or program-based billing as customer products scale.
  • Testing, integration, and value-added processes: higher-margin portions when the work requires complexity (system integration, specialized testing, tighter tolerances, controlled documentation).

Margin drivers in EMS commonly include (i) manufacturing efficiency and labor productivity, (ii) utilization of capacity (absorption of fixed costs), (iii) mix shift toward higher value-added assemblies and testing, and (iv) the ability to manage supply chain volatility and component pricing pass-through mechanics. Working capital efficiency (notably inventory turns and payment terms) also influences free cash flow quality.

🧠 Competitive Advantages & Market Positioning

KE’s moat is best characterized by switching costs and quality/regulatory embeddedness, reinforced by operational cost discipline in complex manufacturing.

  • Switching Costs / Program Qualification: Once a supplier is qualified for a product—especially for applications with stringent testing, traceability, and documented process control—re-qualifying a new manufacturer is costly, time-consuming, and risk-laden. That creates inertia in customer supplier selection.
  • Complexity and Process Know-How: Competence in managing high-mix builds, component integration, and robust test processes supports stickier, longer-duration production programs.
  • Quality Systems as an Intangible Asset: Durable compliance capability (including documentation and process control expectations common in regulated end markets) functions as a barrier to entry and reduces customer perceived risk.
  • Cost & Supply Chain Management: Like peers, KE competes through procurement execution, lean manufacturing, and yield management—efforts that become more valuable as customers demand resilient supply chains.

Competitive benchmarking (industry peers):

  • Flex (flex.com), Sanmina (sanmina.com), and Jabil (jabil.com) are large EMS competitors with broad end-market exposure and scale-based advantages.
  • KE typically positions with a focus on complex manufacturing programs and end-market segments where qualification, quality systems, and process execution carry more weight than pure scale.
  • Compared with large peers that may emphasize diversified breadth, KE’s differentiation relies more on manufacturing execution depth and customer-specific integration work that increases switching friction.

🚀 Multi-Year Growth Drivers

Over a five- to ten-year horizon, KE’s addressable opportunity is supported by structural demand for electronics-intensive products and supply chain reconfiguration:

  • Ongoing electronic content growth: Greater digitization and electrification expand unit volumes and drive more sophisticated assemblies (more testing, higher value-added integration).
  • Medical and industrial complexity: Regulated and mission-critical equipment requires disciplined manufacturing, traceability, and validated processes—conditions that favor qualified suppliers.
  • Supply chain reshoring / nearshoring: Customers increasingly prioritize shorter lead times, diversified manufacturing footprints, and reliable execution. This supports new program sourcing and incremental capacity demand.
  • Outsourcing of specialized manufacturing: OEMs often retain design while outsourcing assembly, testing, and lifecycle production execution to EMS partners with proven process control.

⚠ Risk Factors to Monitor

  • Customer and end-market concentration risk: EMS margins are sensitive to volume swings and program ramp timing across major customers and sectors.
  • Margin pressure from utilization and mix: Fixed-cost absorption is a key driver; underutilization can compress operating margins.
  • Technological and component obsolescence: Rapid design changes can require process adjustments, inventory risk, and retooling.
  • Quality and compliance exposure: For regulated applications, quality escapes can trigger warranty costs, customer remediation, and reputational loss that impacts future program wins.
  • Supply chain and logistics disruptions: Component shortages, lead-time volatility, and freight constraints can affect production schedules and working capital.
  • Contracting terms and pass-through mechanics: Where customers cap component or labor cost variability, EMS operators may face margin headwinds.

📊 Valuation & Market View

Equity markets often value EMS businesses on enterprise value to earnings metrics (such as EV/EBITDA) and earnings power rather than on near-term top-line growth alone. The factors that typically move valuation expectations include:

  • Operating margin durability: evidence of sustained manufacturing efficiency and disciplined cost control.
  • Capacity utilization and backlog/program visibility: smoother ramp patterns support more stable earnings.
  • Cash conversion: working capital efficiency and reliable free cash flow generation can command a valuation premium.
  • Quality track record: lower expected remediation and lower program attrition risk.

Because EMS earnings can be cyclical with end-market demand, investors typically price not only current profitability but also the credibility of margin support through cycles.

🔍 Investment Takeaway

KE’s long-term investment case centers on supplier qualification-driven switching costs, process and quality capability embedded in production programs, and cost discipline that supports value creation when utilization and program mix are favorable. In a sector where competitors often compete on scale, KE’s differentiated positioning emphasizes complex manufacturing execution and sustained customer qualification—attributes that can translate into more defensible program retention and earnings resilience over time.


⚠ AI-generated — informational only. Validate using filings before investing.

```

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for KE.

gurufocus.com2026-07-29

Kimball Electronics, Inc. Announces Date For Reporting Fourth Quarter and Fiscal Year 2026 Financial Results

Kimball Electronics, Inc. (Nasdaq: KE) today announced that it will report fourth quarter and fiscal year 2026 financial results on Wednesday, August 12, 2026,

businesswire.com2026-07-29

Kimball Electronics, Inc. Announces Date For Reporting Fourth Quarter and Fiscal Year 2026 Financial Results

JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced that it will report fourth quarter and fiscal year 2026 financial results on Wednesday, August 12, 2026, after the closing of the market. The company will host a conference call and live webcast to review the results on Thursday, August 13, 2026, at 10:00 a.m. Eastern Time. The telephone number to access the conference call is 877-407-8293 / +1 201-689-8349. A live webcast of the conference call can be accesse.

zacks.com2026-07-23

KE or ROK: Which Is the Better Value Stock Right Now?

Investors with an interest in Electronics - Miscellaneous Products stocks have likely encountered both Kimball Electronics (KE) and Rockwell Automation (ROK). But which of these two companies is the best option for those looking for undervalued stocks?

zacks.com2026-07-23

Wall Street Analysts Believe Kimball Electronics (KE) Could Rally 36.44%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 36.4% in Kimball Electronics (KE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

zacks.com2026-07-22

KE Focuses on Holistic Growth for Sustainability: Reason to Buy?

Kimball is investing in medical manufacturing, automation and acquisitions to support higher margins and sustainable long-term growth.

zacks.com2026-07-20

Is Kimball Electronics (KE) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

businesswire.com2026-07-15

Kimball Electronics Launches Rebrand to Kimball Solutions, Marking First Phase Completion in Jasper and Indianapolis

JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced a significant milestone in its evolution, with the successful completion of the first phase of its rebranding to Kimball Solutions at its Jasper and Indianapolis, Indiana facilities, effective July 1, 2026. This milestone reflects the Company's continued transformation from a traditional electronics manufacturing services (EMS) provider into a global, diversified manufacturing and engineering solutions partner.

zacks.com2026-07-15

Do Options Traders Know Something About Kimball Electronics Stock We Don't?

Investors need to pay close attention to KE stock based on the movements in the options market lately.

zacks.com2026-07-07

KE vs. ROK: Which Stock Is the Better Value Option?

Investors interested in stocks from the Electronics - Miscellaneous Products sector have probably already heard of Kimball Electronics (KE) and Rockwell Automation (ROK). But which of these two companies is the best option for those looking for undervalued stocks?

zacks.com2026-07-07

Wall Street Analysts See a 30.11% Upside in Kimball Electronics (KE): Can the Stock Really Move This High?

The mean of analysts' price targets for Kimball Electronics (KE) points to a 30.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

zacks.com2026-07-07

New Strong Buy Stocks for July 7th

DEC, FTRE, HG, PARR and KE have been added to the Zacks Rank #1 (Strong Buy) List on July 7, 2026.

seekingalpha.com2026-07-01

Kimball Electronics, Inc. (KE) M&A Call Transcript

Kimball Electronics, Inc. (KE) M&A Call Transcript

businesswire.com2026-07-01

Kimball Electronics Acquires European-Based Medical CDMO, Helvoet Polymer Technologies B.V.

JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced the Company acquired Helvoet Polymer Technologies B.V. (“Helvoet”), a Contract Development and Manufacturing Organization (CDMO), based in Europe and with operations in India focused on microfluidics, diagnostics, and drug delivery. The transaction was valued at a purchase price of €90 million (excluding working capital, other customary adjustments, and acquisition-related costs), or approximately $103 million.

globenewswire.com2026-06-12

KE Holdings Inc. Announces Results of Annual General Meeting

BEIJING, June 12, 2026 (GLOBE NEWSWIRE) -- KE Holdings Inc. (“Beike” or the “Company”) (NYSE: BEKE; HKEX: 2423), a leading integrated online and offline platform for housing transactions and services, today announced that each of the proposed resolutions submitted for shareholders' approval (the “Proposed Resolutions”) as set forth in the notice of annual general meeting dated April 24, 2026 has been adopted at the meeting held in Beijing, China today.

zacks.com2026-06-05

Is the Options Market Predicting a Spike in Kimball Electronics Stock?

Investors need to pay close attention to KE stock based on the movements in the options market lately.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"KE reported Q3’26 revenue of $352.9M and net income of $5.72M (EPS $0.23). YoY (vs Q3’25) revenue declined to $374.6M (-5.8% YoY) while net income fell from $3.82M to $5.72M (+49.9% YoY). QoQ (vs Q2’26) revenue rose to $341.3M (+3.4% QoQ) and net income increased from $3.64M to $5.72M (+57.4% QoQ). Profitability improved: net margin expanded to 1.62% from 1.07% QoQ and 1.02% YoY, while operating margin rose to 3.33% from 3.81% QoQ (slight QoQ operating compression) but remained above Q3’25 levels. Cash flow quality was mixed but ended positively. Operating cash flow was $14.9M in Q3’26, up from $6.9M in Q2’26, and the quarter generated $14.9M free cash flow, supported by working-capital inflows. Balance sheet resilience looks stronger: total assets increased to $1.10B while cash and equivalents rose to $82.5M and leverage remains low (net debt of about -$82.5M, i.e., net cash). Shareholder returns are strong on momentum: the stock is up +104.7% over 1 year, with no stated dividend (0% yield in provided data) and modest buybacks (repurchased $5.63M of stock this quarter)."

Revenue Growth

Positive

Revenue was +3.4% QoQ (to $352.9M) but -5.8% YoY (vs $374.6M). Near-term stabilization, but longer YoY contraction.

Profitability

Good

Net income +57.4% QoQ and +49.9% YoY; net margin improved to 1.62% from 1.07% QoQ and 1.02% YoY. Operating margin was 3.33% vs 3.81% QoQ (slight QoQ operating pressure) but stronger than Q3’25.

Cash Flow Quality

Good

Operating cash flow $14.9M and free cash flow $14.9M in Q3’26, improving from Q2’26 OCF of $6.9M. Cash conversion appears supported by working capital; dividend is $0.

Leverage & Balance Sheet

Strong

Total assets rose to $1.10B. Liquidity improved with cash up to $82.5M. Leverage is low with net cash position (net debt about -$82.5M), and equity is not impaired in the latest quarter’s presentation.

Shareholder Returns

Strong

Strong total value momentum: +104.7% 1Y price change. Dividend yield is 0%, but the company repurchased ~$5.63M shares in the quarter, supporting capital appreciation.

Analyst Sentiment & Valuation

Neutral

Price ~$26.81 vs consensus target ~$32 implies upside (~19%). However, provided valuation multiples suggest a relatively rich earnings yield profile, limiting the score.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Kimball Electronics reported Q3 FY26 results broadly in line, with sequential sales up 3.4% and Medical again leading. Reported YoY sales declined due to a prior-year nonrecurring Medical consigned inventory sale, but normalized comparisons show total sales up ~1% and Medical up ~17%, marking the third straight quarter of double-digit Medical growth. Gross margin rose 70 bps to 7.9% despite ongoing Medical CMO ramp, while adjusted diluted EPS increased to $0.33. Cash flow remained strong with positive operating cash flow for the ninth consecutive quarter and improving cash conversion days. Guidance was affirmed, calling for FY26 revenue of $1.4B–$1.46B and adjusted operating margin at the high end of 4.2%–4.5%, implying Q4 revenue $370M–$380M. The main margin risk is the Indianapolis facility ramp, expected to pressure FY27 gross margin by 40–50 bps before abating in FY28. Automotive demand risk is tied to macro/EV incentive volatility, while Industrial faces HVAC softness.

AI IconGrowth Catalysts

  • Medical vertical sequential and normalized year-over-year growth led by respiratory care, imaging systems, drug delivery devices, and blood separation products
  • Medical CMO volume ramp in Indianapolis expected to drive both top-line growth and margin expansion with a stated 18–36 month program path
  • Automotive Poland and Romania steering/braking ramp: combined up 20% in-quarter with expected continuation through balance of 2026

Business Development

  • Medical CMO strategy targeting “lift-and-shift” programs (customers shifting existing manufacturing into Kimball capacity)
  • Target goal: add 5 new Medical customers annually (management stated FY26 is on track)
  • Active M&A evaluation focused on Medical CMO tuck-ins for capabilities (micro-molding, advanced precision injection, high-automation engineering) and U.S. geographic footprint expansion

AI IconFinancial Highlights

  • Net sales: $352.9M in Q3 FY26; +3.4% sequential; -6% YoY reported due to prior-year $24M nonrecurring consigned inventory sale in Medical (normalized: total sales +~1% YoY; Medical +17% YoY)
  • Medical growth: +10% YoY reported; +17% YoY normalized; third consecutive quarter of double-digit Medical growth; Q3 Medical sales $106M (30% of total company)
  • Gross margin: 7.9% in Q3, +70 bps vs 7.2% in Q3 FY25 (mix and easier comparison vs prior-year inventory sale; offset by Medical CMO ramp)
  • Adjusted operating income: $14.8M, 4.2% of net sales (vs $15.7M, 4.2% of net sales prior year—lower dollars but same rate)
  • Adjusted diluted EPS: $0.33 vs $0.27 prior year; adjusted net income $8.0M
  • Selling & admin: 3.7% of sales vs 3.0% prior year (13.0M; +$1.8M YoY); management cited FY26 transformation/IT and business development investment
  • Tax rate: 34.9% in Q3 vs 46.6% in Q3 FY25; FY26 expected ~30% (explanation: prior year interest deductibility limitation)
  • Cash flow: operating cash flow +$14.9M (9th consecutive quarter positive); cash conversion days 90 (improved +1 vs prior quarter; +9 vs Q3 FY25)

AI IconCapital Funding

  • Cash and cash equivalents: $82.5M at March 31, 2026
  • Borrowings: $163M at March 31, 2026 (down ~9% YoY; +$8.8M vs Q2)
  • Unused liquidity: $358.5M total dry powder (cash + unused credit facilities); revolver renewed $300M in April
  • Share repurchase: $4.0M in Q3; 165,000 shares; $6.5M remaining under repurchase program; $113.5M returned since Oct 2015 (7.0M shares)
  • CapEx: $14.4M in Q3; full-year guidance $50M–$60M

AI IconStrategy & Ops

  • Indianapolis manufacturing facility: ~300,000 sq ft; clean rooms installing; expected to begin production by end of calendar year; moving existing Indianapolis production plus new programs
  • CMO facility margin headwind: expected 40–50 bps gross margin impact in FY27 due to ramp costs while current facility still operates; abate in FY28 as utilization increases
  • Inventory reduction: $273.3M end of quarter; down $8.4M vs Q2; down $23.3M (-8%) YoY; CCD improvement attributed to tighter component management/supply chain working capital control (not revenue)

AI IconMarket Outlook

  • Affirmed FY26 guidance: revenue range $1.4B–$1.46B; adjusted operating income margin expected at high end of 4.2%–4.5%
  • Implied Q4: revenue $370M–$380M; adjusted OI margin 4.4%–4.6%
  • Q4 expected to be sequential sales increase with Medical growth outpacing other verticals
  • Monitor macro impacts: war in Iran (higher freight/raw material costs), higher U.S. gas prices, consumer sentiment; Automotive demand affected by EV electronic steering demand and legislative impacts on EV incentives

AI IconRisks & Headwinds

  • Medical CMO ramp timeline risk: management reiterated 18–36 months to CMO revenue; margins face near-term pressure during facility ramp
  • FY27 gross margin risk: 40–50 bps headwind expected from Indianapolis facility ramp
  • Automotive demand volatility risk: reduced EV program demand in North America tied to legislative changes affecting consumer incentives; demand is fluid with U.S. gasoline price changes
  • Industrial headwind: HVAC demand lower in North America; possible near-term impact to green energy/Off-highway/public safety adjacent areas from protracted war in Middle East
  • CMO competitive pricing risk: pricing described as competitive but “rational”; management did not cite irrational pricing, but competition remains a factor

Q&A: Analyst Interest

  • Indianapolis facility ramp economics: Management described ongoing clean-room buildout and approvals, production starting by end of calendar year, and FY27 gross margin headwind of 40–50 bps. They emphasized both “existing program moves” and “new programs” plus lift-and-shift while current facility continues operating.
  • Medical capacity bookings and dependence on new logos: Management said they’re early to quantify booked capacity because the Indianapolis facility is leased and space is reserved for growth. They confirmed a strategy to add new logos to attract capacity-based demand, while existing customers remain active in program discussions.
  • Medical competitive/pricing environment and M&A appetite: Management stated CMO/CDMO pricing is always competitive but “still rational” and supported by supply-chain capacity needs in medical. They highlighted evaluation criteria for Medical CMO tuck-ins for capabilities and U.S. footprint, stating they can act decisively given cash generation and debt comfort.

Sentiment: MIXED

Note: This summary was synthesized by AI from the KE Q3 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for KE.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (KE)

© 2026 Stock Market Info — Kimball Electronics, Inc. (KE) Financial Profile